Daiichi Sankyo (OTCMKTS:DSNKY) Shares Gap Up – Here’s Why

Daiichi Sankyo Co., Ltd. – Sponsored ADR (OTCMKTS:DSNKY)’s stock price gapped up before the market opened on Tuesday . The stock had previously closed at $18.97, but opened at $19.71. Daiichi Sankyo shares last traded at $19.02, with a volume of 19,545 shares trading hands.

Daiichi Sankyo Price Performance

The firm’s fifty day simple moving average is $19.00 and its 200-day simple moving average is $21.94. The firm has a market capitalization of $35.42 billion, a PE ratio of 17.16, a PEG ratio of 1.15 and a beta of -0.35. The company has a quick ratio of 1.85, a current ratio of 2.69 and a debt-to-equity ratio of 0.18.

Daiichi Sankyo (OTCMKTS:DSNKY) last posted its quarterly earnings results on Thursday, January 29th. The company reported $0.30 EPS for the quarter, beating analysts’ consensus estimates of $0.25 by $0.05. Daiichi Sankyo had a net margin of 14.83% and a return on equity of 18.64%. The firm had revenue of $3.65 billion for the quarter, compared to analysts’ expectations of $3.88 billion. On average, research analysts forecast that Daiichi Sankyo Co., Ltd. – Sponsored ADR will post 0.73 earnings per share for the current fiscal year.

Daiichi Sankyo Company Profile

Daiichi Sankyo Co, Ltd. is a global, research-driven pharmaceutical company headquartered in Tokyo, Japan. The company was formed through the merger of Daiichi Pharmaceutical and Sankyo in 2005 and focuses on the discovery, development, manufacturing and commercialization of prescription medicines. Its therapeutic priorities include oncology and cardiovascular disease, and it pursues a mix of small molecules, biologics and antibody‑drug conjugates in its development programs.

Daiichi Sankyo is known for building a development portfolio through both internal research and collaborative partnerships.